Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Aileron Therapeutics Inc (NQ: ALRN )

0.9806 USD -0.0294 (-2.91%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 5, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 503,327
Open 1.000
Bid (Size) 0.9700 (6)
Ask (Size) 1.020 (10)
Prev. Close 1.010
Today's Range 0.9600 - 1.001
52wk Range 0.9100 - 2.470
Shares Outstanding 90,327,848
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Aileron Therapeutics to Participate in Fireside Chat at the William Blair Biotech Focus Conference 2021
From GlobeNewswire News Releases
Aileron Therapeutics Announces Initiation of Randomized, Double-Blind, Placebo-Controlled Trial of ALRN-6924 in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
From GlobeNewswire News Releases

Performance

YTD
-6.61%
-6.61%
1 Month
-16.19%
-16.19%
3 Month
-11.66%
-11.66%
6 Month
-54.60%
-54.60%
1 Year
-33.74%
-33.74%

More News

Read More
Aileron Therapeutics to be Added to the Russell Microcap® Index
From GlobeNewswire News Releases
Aileron Therapeutics to Host KOL Virtual Investor Event Discussing Opportunity for New Paradigm to Protect Cancer Patients from Chemotherapy-Induced Toxicities
From GlobeNewswire News Releases
Aileron Therapeutics Reports First Quarter 2021 Financial Results and Provides Business Update
From GlobeNewswire News Releases
Aileron Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Highlights
From GlobeNewswire News Releases
Aileron Therapeutics to Present at 2021 H.C. Wainwright Global Life Sciences Conference
From GlobeNewswire News Releases
Aileron Therapeutics Announces Enrollment Expansion for Upcoming Phase 1b Clinical Trial of ALRN-6924 in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
From GlobeNewswire News Releases
Aileron Launches Early-Stage Study For Chemoprotective Candidate In Lung Cancer Settings
Tags Non/Small Cell Lung Cancer Biotech Benzinga
From Benzinga
Top Penny Stocks To Buy Now? Analyst Have Targets Up To 386% On 5
Tags Market News
From Penny Stocks to Buy, Picks, News and Information | PennyStocks.com - Feed
Making A List Of Penny Stocks Today? 4 Biotech Names To Watch
Tags Market News
From Penny Stocks to Buy, Picks, News and Information | PennyStocks.com - Feed
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.